Worth a read: “The Solution to Drug Prices” by Eziel Emanuel
WE’RE paying too much for prescription drugs….Despite representing about 1 percent of prescriptions in 2014, these types of high-cost drugs accounted for some 32 percent of all spending on pharmaceuticals….
Almost all developed countries… making drugs available at fixed prices …Drug companies would immediately raise two objections: the high risks associated with drug development and, related, the high cost of research and development. But both of these arguments are fatuous…
Also, as outrageous as they are, prices are not the real issue. Value is. What really frustrates people are expensive drugs that do not provide a cure. For instance, Opdivo adds an average of 3.2 months of life to lung cancer patients and costs $150,000 per year for treatment…
Everyone, including drug company executives, believes that high prices cannot continue. Indeed, that is one reason that companies are trying to maximize profits while they can. We must come up with a comprehensive solution now.
Pingback: 5000% Increase for Well-Established Drug | gutsandgrowth
Pingback: Public Shaming is Not an Effective Drug Pricing Policy | gutsandgrowth
Pingback: Turning Liquid into Gold: A Pharmaceutical Rumpelstiltskin Story | gutsandgrowth
Pingback: Another Shady Pharmaceutical Business Practice: Citizen’s Pathway to Delay Competition | gutsandgrowth